Arkolith/Insider Trading/VTGN/Form 4

Commodore Capital LP

10% OwnerVistagen Therapeutics, Inc. (VTGN) · full profile →Form 4 · filed Oct 6, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2023Grant(A)1.7M——1.7M
Oct 4, 2023Grant(A)1.4M——1.4M
Oct 4, 2023Grant(A)2.8M——2.8M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-23-036497) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML